Malignant Reproductive System Neoplasm — Trials

Malignant Reproductive System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

12,158 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2,804
Recruiting: 1,546
Ph III recruiting: 175
Growth YoY: +16.2%
Industry share: 21%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 27.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,473)

clinicaltrialsPublishedShowing 601–650 of 2,012 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04175431	Prostate Specific Membrane Antigen (PSMA) or (FACBC) PET/CT Site-Directed Therapy for Treatment of Prostate Cancer, Flu-BLAST-PC Study	recruiting	Phase 2	100	University of WashingtonOTHER	1	Jul 7, 2026	clinicaltrials
NCT04765150	Integrating Quantitative MRI and Artificial Intelligence to Improve Prostate Cancer Classification	recruiting	—	275	Jonsson Comprehensive Cancer CenterOTHER	1	Jul 7, 2026